Last year, Medcan director of weight management Dr. David Macklin (pictured above) predicted the diabetes medication semaglutide would be a game changer for those seeking help to lose weight. So we invited back Dr. Macklin to get his perspective on the medication, now that it’s actually on the market and being used by hundreds of thousands of people across North America. Joined by Medcan CMO Dr. Peter Nord, Dr. Macklin explains semaglutide’s benefits, side effects and costs — and describes what’s different about Medcan’s approach to weight management in the semaglutide era.